DANESINO, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 10.118
AS - Asia 7.283
EU - Europa 6.094
SA - Sud America 810
AF - Africa 253
Continente sconosciuto - Info sul continente non disponibili 210
OC - Oceania 34
Totale 24.802
Nazione #
US - Stati Uniti d'America 9.896
CN - Cina 3.787
SG - Singapore 1.571
IE - Irlanda 1.392
UA - Ucraina 868
HK - Hong Kong 682
FI - Finlandia 663
DE - Germania 662
RU - Federazione Russa 619
VN - Vietnam 586
BR - Brasile 584
IT - Italia 506
SE - Svezia 384
FR - Francia 356
GB - Regno Unito 344
ZA - Sudafrica 155
IN - India 140
CA - Canada 114
BD - Bangladesh 96
AR - Argentina 74
ES - Italia 53
NL - Olanda 53
JP - Giappone 52
MX - Messico 51
IQ - Iraq 50
BE - Belgio 46
EC - Ecuador 45
PL - Polonia 43
TR - Turchia 39
PK - Pakistan 36
ID - Indonesia 33
VE - Venezuela 28
CO - Colombia 27
AT - Austria 26
SA - Arabia Saudita 26
AU - Australia 24
MA - Marocco 23
PH - Filippine 23
UZ - Uzbekistan 23
CL - Cile 21
MY - Malesia 18
JO - Giordania 14
TN - Tunisia 13
LT - Lituania 12
CZ - Repubblica Ceca 11
DZ - Algeria 10
IL - Israele 10
IR - Iran 10
NP - Nepal 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
AZ - Azerbaigian 9
EG - Egitto 9
JM - Giamaica 9
NZ - Nuova Zelanda 9
PE - Perù 9
RO - Romania 9
BO - Bolivia 8
ET - Etiopia 8
KE - Kenya 8
PY - Paraguay 8
KR - Corea 7
NI - Nicaragua 7
TH - Thailandia 7
DO - Repubblica Dominicana 6
EU - Europa 6
GT - Guatemala 6
KG - Kirghizistan 6
CH - Svizzera 5
CI - Costa d'Avorio 5
CR - Costa Rica 5
CY - Cipro 5
HN - Honduras 5
OM - Oman 5
AO - Angola 4
GR - Grecia 4
KW - Kuwait 4
MU - Mauritius 4
PA - Panama 4
SM - San Marino 4
SN - Senegal 4
AM - Armenia 3
EE - Estonia 3
GE - Georgia 3
KH - Cambogia 3
LB - Libano 3
MD - Moldavia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
UY - Uruguay 3
BH - Bahrain 2
GA - Gabon 2
GD - Grenada 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
Totale 24.564
Città #
Dublin 1.390
Chandler 1.388
Jacksonville 1.025
San Jose 891
Dallas 856
Nanjing 828
Singapore 820
Ashburn 800
Hong Kong 670
Beijing 619
Boardman 410
Nanchang 337
Council Bluffs 272
Princeton 249
Lawrence 241
Shenyang 240
Medford 233
Changsha 231
Los Angeles 227
Wilmington 227
Hebei 222
Lauterbourg 213
Ann Arbor 202
Jiaxing 191
Ho Chi Minh City 179
New York 178
Hanoi 157
Helsinki 154
Tianjin 148
Johannesburg 142
Hangzhou 135
Munich 131
Shanghai 123
Buffalo 108
Milan 108
Moscow 105
Woodbridge 92
Redondo Beach 78
Santa Clara 70
Turku 66
Pavia 62
São Paulo 59
Toronto 52
Tokyo 51
Verona 50
Orem 49
Houston 47
Frankfurt am Main 46
San Francisco 44
Brussels 43
Seattle 43
Norwalk 39
Warsaw 38
Atlanta 37
London 37
Chicago 36
Falkenstein 34
Montreal 31
Chennai 30
Brooklyn 28
Stockholm 28
Denver 26
Jinan 25
Mexico City 25
Da Nang 23
Des Moines 23
Guangzhou 22
Rome 22
Dhaka 21
Manchester 21
Phoenix 21
The Dalles 20
Amsterdam 19
Fairfield 19
Tashkent 19
Auburn Hills 18
Kunming 18
Rio de Janeiro 18
Belo Horizonte 17
Nuremberg 17
Quito 17
Taizhou 17
Zhengzhou 17
Haiphong 16
Poplar 16
Ankara 14
Biên Hòa 14
Boston 14
Columbus 14
New Delhi 14
Ningbo 14
Amman 13
Baghdad 13
Guayaquil 12
Mumbai 12
Bắc Ninh 11
Riyadh 11
Hải Dương 10
Lahore 10
Washington 10
Totale 16.303
Nome #
Disegnare, attraversare, cancellare i confini. una prospettiva interdisciplinare 225
Advanced magnetic resonance imaging in benign hereditary chorea: study of two familial cases. 175
A Chaperone Enhances Blood α-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy. 162
Bioinformatic Analysis of Pathogenic Missense Mutationsof Activin Receptor Like Kinase 1 Ectodomain 158
Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. 149
A novel mutation and novel features in Nijmegen breakage syndrome. 148
Dietary treatment in adult-onset type II glycogenosis. 148
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 147
Familial platelet disorder with propensity to acute myelogenous leukemia: Genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies 146
Changes in nutritional status and body composition during enzyme replacementtherapy in adult-onset type II glycogenosis. 146
A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. 146
Effect of ionizing radiation exposure on proliferation and cell cycle distribution in cells derived from shwachman-diamond syndrome affected patients 145
Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. 144
The strange case of the lost NRAS mutation in a child with juvenile myelomonocytic leukemia. 144
Dietary treatment in adult-onset type II glycogenosis. 140
Analisi di linkage in 4 famiglie con Rendu Weber Osler. 139
Citochimica, autoradiografia e ultrastruttura di cellule della granulosa ovarica umana "in vitro". 138
Functional analysis of a novel ENG variant in a patient with hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH) identifies a new SP1 binding site 138
A proportion of patients with lymphoma may harbor mutations of the perforin gene 137
Circulating microRNAs In Hereditary Hemorrhagic Telangiectasia: Preliminary Results Identify Significant Differences Among Patients 135
Concurrent cytogenetic and molecular investigations in uterine and ovarian neoplasms 134
Enzyme replacement therapy (ERT) in adult-onset type II glycogenosis (GSDII) 134
Effect of X-rays on DNA repair pathways in lymphoblastoid cell lines derived from Shwachman-Diamond syndrome patients. 134
Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. 133
Can GH induce chromosome breaks or microsatellite instability in GH-deficient children? 133
Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies. 131
Immunohistochemical analysis of a merkeloma observed in a patient affected byhereditary haemorrhagic telangiectasia. 131
Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene 130
Six novel mutations in the PRF! gene in children with haemophagocytic lymphoistiocytosis. 129
Clinical, genetic amd immunologic analysis of a family affected by Ozena. 129
Blood cell mitochondrial DNA content and premature ovarian aging 129
Isochromosome (7) (q10) in Schwachman syndrome without MDS/AML and role of chromosome 7 anomalies in myeloproliferative disorders. 128
Constitutional trisomy 8 as first mutation in multistep carcinogenesis: clinical, cytogenetic and molecular data on three cases 128
Angiotensin converting enzyme gene deletion allele is idenpendently and strongly associated with coronary atherosclerosis and myocardial infraction. 128
Bioinformatics as a Starting Point for the Analysis of ALK1 Missense Mutations 128
A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. 127
Characterization of a mutation in the zona pellucida module of Endoglin that causes Hereditary Hemorrhagic Telangiectasia 126
Familial hemophagocytic lymphohistiocytosis: how late can the onset be? 125
Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2 125
Bioimpedance Phase Angle as a Prognostic Tool in Late-Onset Pompe Disease: A Single-Centre Prospective Study With a 15-year Follow-Up 124
Comment on: Corpus callosum hypoplasia and associated brain anomalies in Nijmegen breakage syndrome. 124
Agenesis of corpus callosumwith mosaicism 46,XY/47,XY extra ring chromosome 124
A homozygous missense arginine to histidine substitution at position 482 of the beta-galactosidase in an Italian infantile GM-1 gangliosidosis patient 124
Parental origin of the deletion del(20q) in Shwachman-Diamond patients and loss of the paternally derived allele of the imprinted L3MBTL1 gene 124
Familial myelodysplastic syndromed, monosomy 7/trisomy 8, and mutator effects. 124
Early onset of gastric carcinoma and constitutional deletion of 18p. 123
Familial clustering of unexplained transient respiratory distress in 12 newborns from three unrelated families suggests an autosomal-recessive inheritance. 123
FAMILIAL PARTIAL MONOSOMY 7 AND MYELODYSPLASIA: DIFFERENT PARENTAL ORIGIN OF THE 7 INVOLVED SUGGESTS THE ACTION OF A MUTATOR GENE 123
Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langherans cell histiocytosis 122
Isochromosome 7q10 in Shwachman Syndrome without MDS/AML and role of chromosome 7 anomalies in myeloproliferative disorders. 122
Interobserver agreement in diagnosing liver involvement in hereditary hemorrhagic telangiectasia by Doppler ultrasound. 122
A liveborn 69,XXX triploid. Origin, X chromosome activity and gene dosage 122
Increase of circulating endothelial cells in patients with Hereditary Hemorrhagic Telangiectasia. 122
Different outcomes of allogeneic hematopoietic stem cell transplant in a pair of twins affected by juvenile myelomonocytic leukemia. 122
Mapping of genes predisposing to familial hemophagocytic lymphohistiocytosis (FHL) using linkage analysis. 120
Rischio di ricorrenza di Sindrome di Turner. 120
Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds. 120
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 119
Recombinant alpha-glucosidase in adult-onset type II glycogenosis: The experience with the first Italian patient, from expanded access programmes to marketing authorization 119
Rendu-Osler-Weber patients have an increasd frequency of mature endothelial cells in peripheral blood 119
STRUCTURAL MODELLING OF ALK1 ECTO-DOMAIN 118
Early-onset ptosis in type II glycogenosis 118
Radiosensitivity and DNA damage repair in Lymphoblastoid cell lines derived from Shwachman-Diamond syndrome patients 118
Pulmonary artery systolic pressure as estimated by TTE in a group of HHT patients. 118
Deficiency 10p. report of a case and exclusion mapping of the Hexokinase 1 locus to band 10p11.2 117
Diagnosis of vascular Ehlers-Danlos syndrome in Italy: Clinical findings and novel COL3A1 mutations 117
Clinical, genetic and immunologic analysis of a family affected by ozena 116
Psychomotor development in cri du chat syndrome: Comparison in two Italian cohorts with different rehabilitation methods 116
Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. 115
Hereditary Hemorrhagic Telangiectasia: Breakpoint Characterization of a Novel Large Deletion in ACVRL1 Suggests the Causing Mechanism. 115
Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman-Diamond Syndrome 114
Meiotic origin of trisomy in neoplasms: evidence in a case of erythroleukemia. 114
Absence of acquired copy number neutral loss of heterozygosity (CN-LOH) of chromosome 7 in a series of 10 patients with Shwachman-Diamond syndrome. 114
Breast cancer and genetics 113
Benign Hereditary Chorea: From clinic to basic research... and back ( Letter ) 113
Functional analysis of a novel ENG variant in a patient with hereditary hemorrhagic telangiectasia (HHT) identifies a new Sp1 binding-site 112
The angiotensin-converting enzyme insertion/deletion polymorphysm modifies the clinical outcome in patients with Pompe disease. 111
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. 111
Isochromosome (7)(q10) in Shwachman Syndrome Without MDS/AML and Role of Chromosome 7 Anomalies in Myeloproliferative Disorders 111
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 111
Genotype-phenotype correlation in Pompe disease, a step forward. 111
Erythroleukaemia with tetrasomy 21 in a child without Down phenotype: evidence for a meiotic origin. 110
Antenatal sex detrmination 110
Experience of an Italian reference laboratory for a rare disease: Hereditary Haemorragic Telangiectasia 110
Does growth hormone treatment increase chromosomal abnormalities? 109
Deletion of PAX9 and oligodontia: a third family and review of the literature. 109
Natural history and outcome of hepatic ascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia 109
Enzyme replacement therapy in adult-onset type II glycogenosis 109
Hereditary Hemorrhagic Telangiectasia: first demonstration of a branch point causative variant. 109
Endoscopic evaluation of gastrointestinal tract in patients with hereditary hemorrhagic telangiectasia and correlation with their genotypes. 108
Types, stability, and phenotypic consequences of chromosome rearrangements leading to interstitial telomeric sequences. 108
Radiosensitivity in lymphoblastoid cell lines derived from Shwachman-Diamond syndrome patients 108
Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients. 108
Does growth hormone treatment increase chromosomal abnormalities 107
JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia 106
Constitutional trisomy 8 mosaicism: mechanism of origin, phenotype variability, and risk of malignancies 105
Cutaneous metaplastic synovial cyst in Ehlers-Danlos syndrome: report of a second case. 104
Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis 102
High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia 102
Ptosis as a feature of late-onset glycogenosis type II. 102
Totale 12.472
Categoria #
all - tutte 102.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.101 0 9 21 14 16 20 19 75 48 32 176 671
2022/20233.893 382 290 68 317 435 401 7 203 1.615 44 94 37
2023/20241.216 156 201 31 96 116 331 24 119 12 31 48 51
2024/20253.284 77 281 89 124 73 141 128 224 826 96 380 845
2025/20267.953 619 823 858 814 1.015 336 1.469 364 696 552 250 157
2026/2027442 157 285 0 0 0 0 0 0 0 0 0 0
Totale 24.802